DNASE1 and chronic obstructive pulmonary disease: DNase-I has been shown to reduce airway inflammation induced by acute CS exposure.23 To explore the therapeutic potential of targeting NETs-DNA to mitigate airway inflammation induced by long-term CS exposure, we employed DNase-I to degrade NETs-DNA in the COPD mouse model.